ASH 2021: myCare-023 Finds Cellworks Personalized Biosimulation a Stronger Predictor of Therapy Response for AML Patients than Physician Prescribed Treatment
Results from myCare-023 Clinical Trial Featured in Oral Presentation at ASH 2021 Annual…
ASH 2021: Cellworks Personalized Therapy Biosimulation Study Identifies Novel Biomarkers Predictive of Response in AML Patients
AML Biomarker Identification Can Improve Clinical Trials for New Drugs and Accelerate Drug…
ASH 2021: Cellworks Personalized Therapy Biosimulation Study Identifies Novel Biomarkers Predictive of Response in Resistance Cases of MCL
Novel Biomarkers Can Help Identify Treatment Alternatives for Relapsed MCL Patients,…
ASH 2021: Cellworks Personalized Biosimulation Study Identifies Novel MDS Biomarkers and Immune Modulation Predictive of Therapy Response
Therapy Biosimulation Can Increase Success of Clinical Trials and Accelerate Approval of…